196 results on '"Cante D"'
Search Results
2. WORSENING OF 2-YEAR PATIENT-REPORTED INTESTINAL FUNCTIONALITY AFTER RADIOTHERAPY FOR PROSTATE CANCER INCLUDING PELVIC NODE IRRADIATION
3. ASSOCIATION OF PERSISTENT URINARY SYMPTOMS WITH QUALITY OF LIFE AFTER PROSTATE CANCER RADIOTHERAPY
4. MO-0220 Two-year impact of bowel symptoms on HRQoL after RT for prostate cancer with pelvic node irradiation
5. PO-1483 Persistent urinary symptoms and long-term quality of life after prostate cancer radiotherapy
6. PD-01.48 - WORSENING OF 2-YEAR PATIENT-REPORTED INTESTINAL FUNCTIONALITY AFTER RADIOTHERAPY FOR PROSTATE CANCER INCLUDING PELVIC NODE IRRADIATION
7. PD-01.46 - ASSOCIATION OF PERSISTENT URINARY SYMPTOMS WITH QUALITY OF LIFE AFTER PROSTATE CANCER RADIOTHERAPY
8. CO-03.1 - USE DOSE OF SURFACE MAPS TO IDENTIFY BLADDER SUB-REGIONS ASSOCIATED WITH LATE TOXICITIES AFTER PROSTATE CANCER RADIOTHERAPY
9. Nasopharyngeal carcinoma in a low incidence European area: A prospective observational analysis from the Head and Neck Study Group of the Italian Society of Radiation Oncology (AIRO)
10. OC-0457 Modeling outcome after salvage post-prostatectomy radiotherapy: impact of pelvic nodes irradiation
11. PD-0414 Trend over time of patient-reported QoL domains after pelvic nodal irradiation for prostate cancer
12. PD-0415 Pelvic RT in prostate cancer: late intestinal toxicity is modulated by severity of acute symptoms
13. PH-0660 Independent role of dose-escalation and prophylactic WPRT in salvage RT after radical prostatectomy
14. PD-0769 Patient-reported acute intestinal toxicity and impact on patient QoL after WPRT for prostate cancer
15. PH-0108 New dose-volume constraints for patient-reported acute bowel toxicity symptoms in whole pelvis IMRT
16. PO-1363 Prediction of urinary toxicity after prostate cancer RT: long term evaluation
17. PO-1342 Trends and predictors of worsening at RT end of anxiety and depression during RT for prostate cancer
18. PO-1345 Symptoms affecting Emotional, Systemic and Social Domains 2 years after RT for prostate cancer
19. PO-1354 Time Dependence of PSADT prognostic threshold in men treated with post-prostatectomy salvage RT
20. PD-0767 Predictors of urinary incontinence 2 years after RT with different intents for prostate cancer
21. PD-0782 Predicting bRFS after salvage post-prostatectomy RT with a “one-size-fits-all” TCP-based formula
22. Independent role of dose-escalation and prophylactic lymph-nodal irradiation in salvage radiotherapy after prostatectomy. A retrospective, multi-institute analysis on 725 men treated with high-dose radiotherapy and eight years follow-up
23. PO-2099 Bladder dose surface maps identify subregions associated to late toxicities after prostate cancer RT
24. PO-1509 Predictors of Patient-Reported decline in Social activity 2-years after WPRT for prostate cancer
25. PD-0059: Patient-reported baseline incontinence at post-prostatectomy RT: its dependence on time from surgery
26. PD-0668: Longitudinal analysis of patient-reported urinary incontinence 2yr after post-prostatectomy RT
27. PH-0366: Predictors of incontinence 2yr after post-prostatectomy RT: evidence of dose & fractionation effects
28. Clinical determination of carbohydrate-deficient transferrin (CDT) in alcohol addicts: A random sample of the general population in Naples, Italy
29. PO-0837 Dose-effect relationship for early late incontinence after IMRT in post-prostatectomy patients
30. PO-0850 Comparison of self-reported acute urinary incontinence in pts treated with adjuvant or salvage IMRT
31. EP-1567 Prospective longitudinal evaluation of quality of life after prostate cancer IMRT
32. PO-0851 Quality of life after whole pelvis RT for prostate cancer: results from a prospective study
33. Comparison of self-reported acute urinary incontinence in patients treated with adjuvant or salvage post-prostatectomy intensity modulated-radiotherapy (IMRT)
34. Dose-effect relationship for 1-year incontinence after post-prostatectomy intensity-modulated radiotherapy (MRT)
35. 47. Dependence from dose and fractionation of late severe urinary toxicities after radical radiotherapy for prostate cancer
36. PV-0320: NTCP models of late severe urinary symptoms after radical IMRT for prostate cancer
37. PO-0826: Factors affecting self-reported, long-term (1-2 yrs) urinary incontinence from post-prostatectomy RT
38. PV-0627: Hematologic toxicity after whole-pelvis irradiation: results of a longitudinal observational study
39. PO-0820: The bowel syndrome after whole pelvis RT for prostate cancer: acute symptoms and quality of life
40. EP-1175: Role of Radiotherapy in the management of metastases from salivary gland carcinoma
41. EP-1598: Patient reported urinary symptoms and 1-2 year anxiety and depression after post-prostatectomy RT
42. PO-0825: Urinary calprotectin as a promising biomarker of RT-induced urinary toxicity. Preliminary results
43. Factors affecting self-reported, long-term (1-2 yrs) urinary incontinence from postprostatectomy RT
44. Quality of life in the first year after RT for prostate cancer: Results from a prospective observational trial
45. Self-reported urinary incontinence from radiotherapy in the treatment of prostate cancer: Effect of RT intent
46. Urinary calprotectin as a promising bio-marker of radiation-induced urinary toxicity and worsening of urinary function. Preliminary results
47. Incidence of Late Severe Urinary Symptoms after Radical IMRT for Prostate Cancer: Effect of Bladder Doses and Hypofractionation
48. Dose-Effect Quantification of Patient-Reported Urinary Incontinence After Radiation Therapy for Prostate Cancer
49. Nasopharynxkarzinom in einem europäischen Gebiet mit geringer Inzidenz: Eine prospektive Beobachtungsanalyse der Kopf- und Hals-Studiengruppe der Italienischen Gesellschaft für Radioonkologie (AIRO)
50. PO-0846: Bowel dose-volume relationship for patientreported acute intestinal toxicity from pelvic IMRT
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.